JP2007505085A - ベンゾイミダゾールアセトニトリル - Google Patents
ベンゾイミダゾールアセトニトリル Download PDFInfo
- Publication number
- JP2007505085A JP2007505085A JP2006525833A JP2006525833A JP2007505085A JP 2007505085 A JP2007505085 A JP 2007505085A JP 2006525833 A JP2006525833 A JP 2006525833A JP 2006525833 A JP2006525833 A JP 2006525833A JP 2007505085 A JP2007505085 A JP 2007505085A
- Authority
- JP
- Japan
- Prior art keywords
- ethyl
- benzimidazol
- dihydro
- acetonitrile
- ylidene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*C(C#N)=C1N(*)C(C=C*(*)C=C2)=C2N1 Chemical compound C*C(C#N)=C1N(*)C(C=C*(*)C=C2)=C2N1 0.000 description 1
- CIIHNUDGWLITEY-OQKWZONESA-N CCCN(c1ccccc1N1)/C1=C(/c1ccnc(NCCCN(CCC2)C2=O)n1)\C#N Chemical compound CCCN(c1ccccc1N1)/C1=C(/c1ccnc(NCCCN(CCC2)C2=O)n1)\C#N CIIHNUDGWLITEY-OQKWZONESA-N 0.000 description 1
- BDVRGJYUNPECCL-XDJHFCHBSA-N CCN(c(cccc1)c1N1)/C1=C(/c1c(C)cnc(NC(C2CNCC2)=O)n1)\C#N Chemical compound CCN(c(cccc1)c1N1)/C1=C(/c1c(C)cnc(NC(C2CNCC2)=O)n1)\C#N BDVRGJYUNPECCL-XDJHFCHBSA-N 0.000 description 1
- TWVIABSIGJNAFU-CAPFRKAQSA-N CCN(c(cccc1)c1N1)/C1=C(/c1c(C)cnc(NC(C2CNCCC2)=O)n1)\C#N Chemical compound CCN(c(cccc1)c1N1)/C1=C(/c1c(C)cnc(NC(C2CNCCC2)=O)n1)\C#N TWVIABSIGJNAFU-CAPFRKAQSA-N 0.000 description 1
- IUFUJANTQSVQNN-LYBHJNIJSA-N CCN(c(cccc1)c1N1)/C1=C(/c1c(C)cnc(NC(CCNC(c2ccccc2)=O)=O)n1)\C#N Chemical compound CCN(c(cccc1)c1N1)/C1=C(/c1c(C)cnc(NC(CCNC(c2ccccc2)=O)=O)n1)\C#N IUFUJANTQSVQNN-LYBHJNIJSA-N 0.000 description 1
- DDVNZPBCWLCHHP-CAPFRKAQSA-N CCN(c(cccc1)c1N1)/C1=C(/c1c(C)cnc(NCC[n]2cncc2)n1)\C#N Chemical compound CCN(c(cccc1)c1N1)/C1=C(/c1c(C)cnc(NCC[n]2cncc2)n1)\C#N DDVNZPBCWLCHHP-CAPFRKAQSA-N 0.000 description 1
- GUXDLARGZVOOCD-RELWKKBWSA-N CCN(c(cccc1)c1N1)/C1=C(/c1c(C)cnc(NCCc2ccccn2)n1)\C#N Chemical compound CCN(c(cccc1)c1N1)/C1=C(/c1c(C)cnc(NCCc2ccccn2)n1)\C#N GUXDLARGZVOOCD-RELWKKBWSA-N 0.000 description 1
- RHSQSWWCNGUHFC-HEHNFIMWSA-N CCN(c1ccccc1N1)/C1=C(/c1c(C)cnc(NC2CCN(C)CC2)n1)\C#N Chemical compound CCN(c1ccccc1N1)/C1=C(/c1c(C)cnc(NC2CCN(C)CC2)n1)\C#N RHSQSWWCNGUHFC-HEHNFIMWSA-N 0.000 description 1
- NONXXORVPNOQQJ-RELWKKBWSA-N CCN(c1ccccc1N1)/C1=C(/c1c(C)cnc(NCC2CCCCC2)n1)\C#N Chemical compound CCN(c1ccccc1N1)/C1=C(/c1c(C)cnc(NCC2CCCCC2)n1)\C#N NONXXORVPNOQQJ-RELWKKBWSA-N 0.000 description 1
- MEOMSDMEOGJTJP-CAPFRKAQSA-N CCN(c1ccccc1N1)/C1=C(/c1c(C)cnc(NCC[n]2nccc2)n1)\C#N Chemical compound CCN(c1ccccc1N1)/C1=C(/c1c(C)cnc(NCC[n]2nccc2)n1)\C#N MEOMSDMEOGJTJP-CAPFRKAQSA-N 0.000 description 1
- HQTPOPANUWBDHD-UHFFFAOYSA-N Cc(cn1)c(C(C#N)=C2Nc(cccc3)c3N2)nc1Cl Chemical compound Cc(cn1)c(C(C#N)=C2Nc(cccc3)c3N2)nc1Cl HQTPOPANUWBDHD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03102741 | 2003-09-12 | ||
PCT/EP2004/052137 WO2005026155A1 (en) | 2003-09-12 | 2004-09-10 | Benzimidazole acetonitriles |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007505085A true JP2007505085A (ja) | 2007-03-08 |
JP2007505085A5 JP2007505085A5 (no) | 2007-10-11 |
Family
ID=34306922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006525833A Pending JP2007505085A (ja) | 2003-09-12 | 2004-09-10 | ベンゾイミダゾールアセトニトリル |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1667995A1 (no) |
JP (1) | JP2007505085A (no) |
AU (1) | AU2004272306A1 (no) |
CA (1) | CA2534317A1 (no) |
IL (1) | IL174135A0 (no) |
NO (1) | NO20061614L (no) |
WO (1) | WO2005026155A1 (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE479687T1 (de) | 2004-10-15 | 2010-09-15 | Takeda Pharmaceutical | Kinaseinhibitoren |
EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
WO2007025177A2 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Pde阻害による神経新生の調節 |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
EP2382975A3 (en) | 2006-05-09 | 2012-02-29 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
GEP20135728B (en) | 2006-10-09 | 2013-01-25 | Takeda Pharmaceuticals Co | Kinase inhibitors |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
CN113281309B (zh) * | 2021-05-17 | 2022-03-01 | 深圳市罗湖区人民医院 | 一种毒死蜱、多菌灵、阿特拉津三合一检测方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002020495A2 (en) * | 2000-09-06 | 2002-03-14 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
JP2003519142A (ja) * | 1999-12-24 | 2003-06-17 | アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ | ベンザゾール誘導体と、そのjnkモジュレータとしての利用法 |
-
2004
- 2004-09-10 WO PCT/EP2004/052137 patent/WO2005026155A1/en active Application Filing
- 2004-09-10 AU AU2004272306A patent/AU2004272306A1/en not_active Abandoned
- 2004-09-10 EP EP04766767A patent/EP1667995A1/en not_active Withdrawn
- 2004-09-10 CA CA002534317A patent/CA2534317A1/en not_active Abandoned
- 2004-09-10 JP JP2006525833A patent/JP2007505085A/ja active Pending
-
2006
- 2006-03-06 IL IL174135A patent/IL174135A0/en unknown
- 2006-04-10 NO NO20061614A patent/NO20061614L/no not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003519142A (ja) * | 1999-12-24 | 2003-06-17 | アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ | ベンザゾール誘導体と、そのjnkモジュレータとしての利用法 |
WO2002020495A2 (en) * | 2000-09-06 | 2002-03-14 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
Also Published As
Publication number | Publication date |
---|---|
CA2534317A1 (en) | 2005-03-24 |
WO2005026155A1 (en) | 2005-03-24 |
AU2004272306A1 (en) | 2005-03-24 |
NO20061614L (no) | 2006-04-10 |
EP1667995A1 (en) | 2006-06-14 |
IL174135A0 (en) | 2006-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102384668B1 (ko) | Apj 효능제로서의 6-히드록시-5-(페닐/헤테로아릴술포닐)피리미딘-4(1h)-온 | |
US11390616B2 (en) | Apelin receptor agonists and methods of use | |
TWI744301B (zh) | 做為apj促效劑之6-羥基-4-側氧-1,4-二氫嘧啶-5-甲醯胺 | |
US9242977B2 (en) | Trk-inhibiting compound | |
US7371767B2 (en) | Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 | |
JP6346862B2 (ja) | オレキシンレセプターアンタゴニストとしての置換プロリン/ピペリジン | |
TWI557127B (zh) | 布魯頓氏酪胺酸激酶抑制劑 | |
CA2486187C (en) | Kinase inhibitors | |
JP5221453B2 (ja) | イミダゾール誘導体 | |
US8729271B2 (en) | Glycine transporter inhibiting substances | |
JP5529827B2 (ja) | TNFαシグナル伝達のモジュレータ | |
TW201720796A (zh) | 作為apj促效劑之2,4-二羥基菸鹼醯胺 | |
AU2014234907B2 (en) | Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors | |
IL259791A (en) | Peptide 2 receptor agonists 2 pipidinone formyl and 1 formyl peptide receptor agonists | |
IL171708A (en) | History of pyridinyl acetonitrile for use in the preparation of certain new drugs and their preparation | |
TW201534585A (zh) | 二氫吡啶酮mgat2抑制劑 | |
JP2007505085A (ja) | ベンゾイミダゾールアセトニトリル | |
US20060293297A1 (en) | Cyanofluoropyrrolidine derviative | |
US20070185104A1 (en) | Benzoxazole acetonitriles | |
US20070203134A1 (en) | Benzimidazole Acetonitriles | |
TW201247647A (en) | Glycine transport inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070827 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070827 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20080625 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101116 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110510 |